| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 30.189 | 41.542 | 54.385 | 62.598 | 62.718 | 71.831 | 88.329 | 106.372 |
| Total Income - EUR | - | 0 | 30.396 | 41.543 | 54.386 | 64.666 | 62.719 | 71.832 | 88.331 | 106.413 |
| Total Expenses - EUR | - | 2.995 | 25.028 | 24.874 | 29.099 | 35.872 | 34.631 | 34.942 | 39.273 | 40.151 |
| Gross Profit/Loss - EUR | - | -2.995 | 5.367 | 16.669 | 25.287 | 28.795 | 28.087 | 36.890 | 49.057 | 66.262 |
| Net Profit/Loss - EUR | - | -2.995 | 5.063 | 16.253 | 24.743 | 28.373 | 27.485 | 36.172 | 48.174 | 63.069 |
| Employees | - | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Balthazar Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 113 | 965 | 705 | 494 | 233 | 0 | 450 | 307 | 164 |
| Current Assets | - | 87 | 4.461 | 14.193 | 38.960 | 63.940 | 29.497 | 38.018 | 51.389 | 66.043 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 279 | 903 | 161 | 728 | 929 | 696 | 4.711 | 728 |
| Cash | - | 87 | 4.182 | 13.290 | 38.799 | 63.212 | 28.569 | 37.322 | 46.677 | 65.315 |
| Shareholders Funds | - | -2.951 | 2.162 | 13.863 | 38.337 | 60.796 | 27.956 | 36.635 | 48.635 | 63.528 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 3.152 | 3.264 | 1.035 | 1.117 | 3.377 | 1.542 | 1.833 | 3.060 | 2.679 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Balthazar Med Srl